3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
5
Ovarian Neoplasms
2
Colorectal Neoplasms
2
Tuberous Sclerosis
1
Pyloric Stenosis, Hypertrophic
1
Prostatic Neoplasms
1
Pediatric Solid Tumor
1
Pancreatic Neoplasms
1
Neoplasms, Unknown Primary
1
Neoplasms
1
Lymphangioleiomyomatosis
1
Histiocytosis, Non-Langerhans-Cell
1
Histiocytosis, Langerhans-Cell
1
HER2-positive Breast Cancer
1
Early Detection of Cancer
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Castleman Disease
1
Breast Screening
1
Breast Neoplasms, Male
1
Brain Neoplasms
1
Anatomic Stage II Breast Cancer AJCC v8
1
Interventions
Bevacizumab
35
durvalumab
23
atezolizumab
22
Nivolumab
20
lenvatinib
19
tremelimumab
16
Specimen Handling
14
Magnetic Resonance Spectroscopy
12
sintilimab
11
pembrolizumab
9
Ipilimumab
9
tislelizumab
7
Sorafenib
7
cabozantinib
5
X-Rays
5
Immunoglobulin G
5
Disulfides
5
Cyclophosphamide
5
regorafenib
4
Radiotherapy
4
Radiosurgery
4
Radiation
4
Oxaliplatin
4
Immunotherapy
4
Ethiodized Oil
4
fludarabine
3
donafenib
3
Surgical Procedures, Operative
3
Folfox protocol
3
Fluorouracil
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Hepatocellular
×
Genetic Testing
×
90 days
×
Clear all
No trials found.